Navigation Links
BioNeutral's Ygiene(TM) Hospital Grade Antimicrobial Demonstrates a 99.9997% Kill Rate Against Clostridium Difficile Spores (C.diff) in Independent Lab Pre-testing Phase
Date:7/9/2009

NEWARK, N.J., July 9 /PRNewswire-FirstCall/ -- BioNeutral Group, Inc. ("BioNeutral") (OTC Bulletin Board: BONU), a chemical technology-based Life Science company announced today that at ATS Labs, using a Quantitative Disk Carrier test starting with 5.5 million Clostridium Difficile (C.diff) spores, BioNeutral's Ygiene(TM) Hospital Grade antimicrobial delivered an amazing 99.9997% kill.

Clostridium Difficile, an extremely dangerous and difficult to eradicate spore, is associated with hospital acquired infections which results in diverted health care providers' efforts, millions of dollars in extra health care expenses, and tens of thousands of unnecessary deaths annually in the United States alone. The best high powered antimicrobial currently used in hospitals as a disinfectant is based upon quaternary ammonium compounds which are ineffective at eradicating Clostridium Difficile spores, resulting in a serious unmet need in the health care arena.

According to Wyeth, a global leader in pharmaceuticals and consumer healthcare products, in the United States, hospital-acquired infections alone afflict nearly 2 million patients and kill approximately 90,000 people annually, more than diabetes or influenza/pneumonia.

About 70% of these hospital-acquired infections are resistant to at least one drug and nosocomial infections, which costs U.S. society between $4 billion and $5 billion annually.

Dr. Andrew Kielbania, Chief Scientist at BioNeutral, stated, "At BioNeutral we have raised the bar in terms of developing superior antimicrobial formulations. Clostridium Difficile spores represents a significant health threat and also is one of the most difficult to eradicate spores in the heath care area. These impressive independent lab pre-testing results not only validate our internal results but also give us great confidence that our ongoing EPA registration of our Ygiene(TM) Hospital Grade Antimicrobial will be
'/>"/>

SOURCE BioNeutral Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioNeutrals Ygiene(TM) New Hospital Grade Disinfectant Will Save Lives and Billions of Dollars Annually at Health Care Facilities Around the World
2. Galichia Heart Hospital Partners with Mobile Surgery International to Develop Wichita-based Center of Excellence with Global Convenience(TM)
3. GeoVax Signs HIV/AIDS Vaccine Proposal With Health and Hospital System of Cook County, Illinois
4. Cumberland Pharmaceuticals Provides Hospital In-Service Webcast for Acetadote(R)
5. Fate Therapeutics Granted Exclusive License for Stem Cell Modulators by Childrens Hospital Boston and Massachusetts General Hospital
6. CPM Resource Center and The Shams Group Partner To Help Hospitals Integrate Evidence-Based Clinical Content Into Information Systems
7. University of Illinois Medical Center in Chicago First Hospital to Install Innovative Shape-HF™ Cardiopulmonary Testing System
8. New Hospital Energy Performance Service Helps Hospitals Cut Energy Costs by 25% or More
9. TeleHealth Services Chosen by Baptist Hospital East in Development of New Park Tower
10. Vancouver General Hospital is the First Canadian Institution to Implement Copan WASP(R): Walk-Away Specimen Processor
11. Authentidate Teams with Nortel to Enhance Hospital Patient Discharge and Placement Processes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Clara, CA (PRWEB) June 18, 2013 ... to standard size SEMs but have limited performance and ... lower resolution. Full size SEMs would normally provide better ... more knowledge to operate and have a higher cost ... address the gap between these two types of ...
(Date:6/18/2013)... electric cars could be on roads across North America before ... by the United States Department of Energy, Los Alamos National ... is part of a team led by the Los Alamos ... expensive platinum catalysts in fuel cells. , "One of the ... is the cost of the units. The pure platinum needed ...
(Date:6/18/2013)... China Cord Blood Corporation (NYSE: ... of cord blood collection, laboratory testing, hematopoietic stem cell ... preliminary unaudited financial results for the fourth quarter and ... 2013. Fourth Quarter of Fiscal 2013 ... fiscal 2013 increased by 33.3% to RMB133.0 million ($21.4 ...
(Date:6/18/2013)... York, NY (PRWEB) June 18, 2013 ... innovation and sustainability, the Consulate General of Switzerland in ... solar boat, Switzerland’s MS Tûranor PlanetSolar , to ... part of its DeepWater Expedition 2013 tour with scientists ... led by Capitain Gérard d’Aboville, runs exclusively on energy ...
Breaking Biology Technology:Nanounity Introduces the Pemtron Range of Compact Scanning Electron Microscopes 2Nanounity Introduces the Pemtron Range of Compact Scanning Electron Microscopes 3US and Canadian researchers drive towards cheaper fuel cells for electric cars 2China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 2China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 3China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 4China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 5China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 6China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 7China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 8China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 9China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 10China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 11China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 12China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 13Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 2Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 4
... - The nation's fifth largest school district is being ... Johnson Controls, Inc. , to deter sexual predators from ... its attempts to develop hybrid car batteries and energy-efficient ... next month, utilizing digital identification checkpoints in 250 ...
... M ilwaukee, Wis. - Teresa Esser ... Wisconsin and, as the new director of the Milwaukee-based ... to see more of that opportunity realized. , ,While ... of capital in Wisconsin, particularly in the tech sector, ...
... a modest renewable fuel standard contained in the Energy ... and Congressman Ron Kind have called for a ... appearance at the Farmers Cooperative Shipping and Supply Association, Doyle ... the RFS, and they touted the economic and energy independence ...
Cached Biology Technology:Florida schools employ Johnson Controls technology to stop sex predators 2New Silicon Pastures director envisions more home cooking for Wisconsin angels 2New Silicon Pastures director envisions more home cooking for Wisconsin angels 3New Silicon Pastures director envisions more home cooking for Wisconsin angels 4New Silicon Pastures director envisions more home cooking for Wisconsin angels 5New Silicon Pastures director envisions more home cooking for Wisconsin angels 6Doyle, Kind call for higher renewable fuel standard 2Doyle, Kind call for higher renewable fuel standard 3
(Date:6/18/2013)... June 19, 2013  Paris Air Show – ... Test Systems) , a leading provider of innovative ... is demonstrating its solutions this week at the ... With growing challenges including increasingly complex armament systems ... feature-rich, specialized aerospace test solutions that address legacy ...
(Date:6/18/2013)... of Medicine have discovered a mechanism that is used ... component of blood typically associated with clotting, were discovered ... seal it off from the rest of the body. ... this week, provide the science community with a ... known that platelets do participate in immunity, but now ...
(Date:6/18/2013)... Department,s National Renewable Energy Laboratory (NREL), and the ... describing a novel cellulose-degrading enzyme from a marine ... as the gribble. , Gribbles are biologically ... to produce their own enzymes instead of using ... eat. New biomass-degrading enzymes from novel sources such ...
Breaking Biology News(10 mins):Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 2Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 3Immunity mechanism discovered 2Novel enzyme from tiny gribble could prove a boon for biofuels research 2
... moderate to severe chest pains (angina) who have not ... gene therapy approach being used by cardiologists at Rush ... the heart. , The phase II clinical research study ... of a solution containing a DNA plasmid that is ...
... Implanted devices intended to optimize the cardiac function of ... which patients might be at higher risk of dying ... University Medical Center. , Besides maintaining optimal electrical stimulation ... defibrillation) devices are giving cardiologists a new view of ...
... has used gene therapy in two separate studies to ... and rats with a drug-induced form of Parkinson's disease. ... Brain and The Journal of Neuroscience, essentially describes one ... another strategy to treat the devastating side effects that ...
Cached Biology News:Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments 2Implanted Devices Detect High-Risk Heart Failure Patients 2Implanted Devices Detect High-Risk Heart Failure Patients 3Gene therapy for Parkinson's disease moves forward in animals 2Gene therapy for Parkinson's disease moves forward in animals 3Gene therapy for Parkinson's disease moves forward in animals 4
... 'The DNAscope V is a ... microarray scanning and image processing that deliver ... V is a high quality microarray scanner ... imaging technology for optimal background rejection and ...
... Phospho-Specific(Thr 222 ) ... 10 mM sodium HEPES, 100 ... 7.5. Recognizes the ~47 kDa ... (MAPKAPK-2) protein phosphorylated at Thr ...
Anti-Src-Like Adaptor Protein-2 AVOID FREEZE/THAW CYCLES. Recognizes the ~25 and ~28 kDa forms SLAP-2....
Goat polyclonal to Centaurin alpha 2**...
Biology Products: